Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for treatment of delirium in critically ill ICU patients
IRCT20141209020258N189Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in delirium, sponsored by Arak University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20141209020258N189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N189.